Pfizer
PFE
PFE
2,045 hedge funds and large institutions have $140B invested in Pfizer in 2017 Q2 according to their latest regulatory filings, with 83 funds opening new positions, 813 increasing their positions, 909 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,045
Holders Change
-25
Holders Change %
-1.21%
% of All Funds
51.06%
Holding in Top 10
162
Holding in Top 10 Change
-17
Holding in Top 10 Change %
-9.5%
% of All Funds
4.04%
New
83
Increased
813
Reduced
909
Closed
86
Calls
$1.09B
Puts
$1.24B
Net Calls
-$144M
Net Calls Change
+$358M
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$2B |
| 2 |
Lazard Asset Management
New York
|
$577M |
| 3 |
CWM
CIBC World Markets
New York
|
$40.1M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
$338M |
| 5 |
Bank of New York Mellon
New York
|
$2.16B |
